Recombinant SARS-CoV-2 Nucleocapsid antibody
Quick Overview for Recombinant SARS-CoV-2 Nucleocapsid antibody (ABIN7670449)
Target
See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Chimeric human monoclonal to SARS-CoV-2 (2019-nCov) Nucleocapsid Protein
-
Specificity
- This antibody reacts to Nucleocapsid Protein of SARS-CoV-2 (2019-nCov)
-
Purification
- Protein A affinity purified from an animal origin-free culture supernatant
-
Immunogen
- A recombinant 2019-nCov Nucleocapsid Protein expressed in E.coli.
-
-
-
-
Application Notes
- Use at an assay dependent concentration. Assay dependent false.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 50 % Glycerol/PBS with 1 % BSA and 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20.0°C
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Alternative Name
- Nucleocapsid Protein (SARS-CoV-2)
-
Target Type
- Viral Protein
Target
-